Stay updated with breaking news from Certain Patients. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ORION CORPORATION PRESS RELEASE05 JANUARY 2023 at 13:45 EET Orion and MSD Announce Initiation of Two Phase 3 Trials Evaluating ODM-208/MK5684 in Certain...
NICE Recommends VENCLYXTO®▼(Venetoclax) Combination in Certain Patients with the Aggressive Blood Cancer Acute Myeloid Leukaemia (AML) ­ Venetoclax in combination with azacitidine will be immediately available tountreated adult patients with AML unable to recei...
COSMOS trial results in patients with psoriatic arthritis fit with the expectation that "people who've previously failed a TNF inhibitor might be a little less likely to respond to guselkumab."
Eli Lilly news - updated 24/7/365. We link to the best sources from around the world. Covering the latest share price, drug news and more. Get the latest news
According to a study performed by Kaiser Permanente, the use of continuous glucose monitors is linked to improved blood sugar control and fewer emergency department visits for hypoglycemia, specifically for patients suffering from insulin-treated type 2 diabetes. The study was published in the JAMA journal on June 2nd, 2021.